Cancer Diagnostics – Products

Product News
RainDance Launches the Next Generation of PCR
New RainDrop™ System surpasses all existing digital PCR technologies and establishes new performance standards in cancer research.

Product News
Transgenomic and MD Anderson Collaborate on Circulating Tumor Cell Study using ICE COLD-PCR
Teams join forces to evaluate the use of Transgenomic’s very high sensitivity ICE COLD-PCR mutation detection technology in analysis of DNA isolated from circulating tumor cells (CTCs) in blood samples from patients with advanced cancer.

Product News
New Primers Increase Assay Confidence and Improve Sensitivity
Swift Biosciences, Inc. today announced their new line of myT™ Primer reagents for the detection of key cancer mutations.

Product News
Georgia Tech Develops Computational Algorithm
High-throughput DNA sequencing technologies are leading to a revolution in how clinicians diagnose and treat cancer. The molecular profiles of individual tumors are beginning to be used in the design of chemotherapeutic programs optimized for the treatment of individual patients.

Product News
Samsung Biologics Selects QUMAS Platform
QUMAS compliance platform to manage compliance across the organization.

Product News
Study Signals Arrival of Droplet Digital™ PCR
A new, high-throughput digital PCR technology called Droplet Digital PCR™ (ddPCR™) was shown to provide an absolute measure of nucleic acids in a sample in the November 15 issue of Analytical Chemistry.

Whitepaper
Dolomite and Clearbridge BioMedics develop revolutionary instrument for cancer detection

Product News
Smart Cancer Diagnostics from Austria Impresses in Italy
tecnet supports successful sales partnership of Anagnostics.

Product News
Radient Pharmaceuticals' Onko-Sure® Cancer Test Available Through NeoloMed BioSciences
Increased availability of Onko-Sure® in Northeast US.

Product News
Thermo Fisher Scientific Launches New LIMS for Clinical Laboratories at AACC 2011
Thermo Scientific Clinical LIMS delivers a lab-centric solution for patient-centric results.
Advertisement